MEDRx Co., Ltd. (4586) said on Nov. 17 that all 147,820 of its 35th series stock acquisition rights issued in June have been exercised, bringing estimated net proceeds to ¥718 million.
The warrants, which carry an exercise-price adjustment clause, were issued on June 5, 2026 through a third-party allotment to Growth Capital Co., Ltd. With the payment made on Nov. 17, no unexercised rights remain.
In November, 28,396 rights were exercised, or 19.21% of the total issued, resulting in the delivery of 2,839,600 new shares. No treasury shares were used. The exercise price was ¥44 on Nov. 2 and ¥37 from Nov. 9.
| Item | Figure |
|---|---|
| Rights exercised in November | 28,396 |
| Shares delivered in November | 2,839,600 |
| November exercise price | ¥44 / ¥37 |
| Funds raised (estimated net proceeds) | ¥718 million |
Under the exercise restrictions of Tokyo Stock Exchange listing rule 434, shares delivered in November totaled 2,839,600 against 59,365,100 listed shares at the time of issuance payment, an exercise ratio of 4.78%.
Shares outstanding rose to 74,147,100 as of Nov. 17 from 71,307,500 at the end of October, which included two treasury shares. Capital stood at ¥418 million. The company referred readers to its May 20, 2026 announcement for details of the issuance.
| I-ne | |
| Tender offer price | ¥2,248 per share |
| Kadoya Seiyu | |
| Tender offer price | ¥2,655 per share |
| TKP Corporation | |
| Effective date | March 1, 2027 (scheduled) |
| M3, Inc. | |
| Tender offer price | ¥1,619 per share |
| Digital Hearts Holdings | |
| Consolidation ratio | 2,975,211 shares into 1 share |
| Shoei Corporation | |
| Shares transferred | 1.8 million shares |
| TOSE Co., Ltd. | |
| Effective date (scheduled) | Jan. 4, 2027 |
| NSK Ltd. | |
| Share transfer ratio (NSK:NTN) | 1:0.353 |
| M&A / TOB | 20 |
| Guidance | 7 |
| Buybacks | 11 |
| Dividends | 4 |
| Capital | 12 |
| Earnings | 16 |
| People | 3 |
Summaries of public disclosures by Japanese listed companies. Not investment advice; accuracy not guaranteed. Figures and dates in the TDnet originals prevail.
本站內容為日本上市公司公開開示之摘要整理,非投資建議,亦不保證正確。數字與日程以 TDnet 原文為準。
本サイトは日本の上場企業の適時開示を要約したものであり、投資助言ではありません。正確性は保証しません。数値・日程は TDnet の原文が優先します。